ANZUP 2023 | The effects of post-RPLND retrograde ejaculation in men with testicular cancer

Ciara Conduit, FRACP, MBBS, PGCert MEd, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the potential effects of retrograde ejaculation in patients with testicular cancer who have undergone retroperitoneal lymph node dissection (RPLND). Patients in a survey conducted during the PREPARE trial (ACTRN12622000537752) reported that the benefits associated with not having testicular cancer overcame the effects of retrograde ejaculation. However, overall satisfaction depended on age, sexual needs and resulting fertility. More communication is needed with patients to discuss their needs and whether retrograde ejaculation affects them. This interview took place at the Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group annual scientific meeting in Melbourne, Australia.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.